Retrofitting of Continuous Glucose Monitoring Traces Allows More Accurate Assessment of Glucose Control in Outpatient Studies

Diabetes Technology and Therapeutics

Volumn 17, Issue 5, 2015, Pages 355-363

  Del Favero, Simone ^a   Facchinetti, Andrea ^a   Sparacino, Giovanni ^a   Cobelli, Claudio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

ARTICLE; BLOOD GLUCOSE MONITORING; CLASSIFICATION ALGORITHM; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; GOLD STANDARD; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; PRIORITY JOURNAL; REFERENCE VALUE; ALGORITHM; AMBULATORY CARE; ANALYSIS; ARTIFICIAL PANCREAS; BLOOD; CLINICAL TRIAL; DEVICES; MEASUREMENT ACCURACY; STATISTICS AND NUMERICAL DATA; TIME;

ALGORITHMS; AMBULATORY CARE; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DATA ACCURACY; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIA; PANCREAS, ARTIFICIAL; REFERENCE VALUES; TIME FACTORS;

EID: 84934289684     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2014.0230     Document Type: Article

References (17)

1. Cobelli C, Renard E, Kovatchev B: Artificial pancreas: past, present, future. Diabetes 2011;60:2672-2682.
2. Beck RW, Calhoun P, Kollman C: Challenges for outpatient closed loop studies: how to assess efficacy. Diabetes Technol Ther 2013;15:1-3.
3. Thabit H, Hovorka R: Closed-loop insulin delivery in type 1 diabetes. Endocrinol Metab Clin North Am 2012;41: 105-117.
4. Doyle F III, Huyett L, Bok Lee J, Zisser HC, Dassau E: Engineering the artificial pancreas. Diabetes Care 2014;37: 1191-1197.
5. Kovatchev B, Breton M: Retroactive adjustment of continuos glucose monitoring (CGM) data enabling the use of CGM for the assessment of primary study endpoints. Unpublished document for the Food and Drug Administration, Bethesda, MD. Available from the authors.
6. Hovorka R, Nodale M, Haidar A, Wilinska M: Assessing performance of closed-loop insulin delivery systems by continuous glucose monitoring: drawbacks and way forward. Diabetes Technol Ther 2013;15:4-12.
7. Mitre TM, Legault L, Rabasa-Lhoret R, Haidar A: Analysis of continuous glucose monitoring data to assess outpatient closed-loop studies: considerations for different sensors. Diabetes Technol Ther 2014;16:326-327.
8. Del Favero S, Facchinetti A, Sparacino G, Cobelli C: Improving accuracy and precision of glucose sensor profiles: retrospective fitting by constrained deconvolution. IEEE Trans Biomed Eng 2014;61:1044-1053.
9. Kollman C, Calhoun P, Lum J, Sauer W, Beck RW: Evaluation of stochastic adjustment for glucose sensor bias during closed-loop insulin delivery. Diabetes Technol Ther 2014;16:186-192.
10. Luijf YM, DeVries JH, Zwinderman K, Leelarathna L, Nodale M, Caldwell K, Kumareswaran K, Elleri D, Allen JM, Wilinska ME, Evans ML, Hovorka R, Doll W, Ellmerer M, Mader JK, Renard E, Place J, Farret A, Cobelli C, Del Favero S, Dalla Man C, Avogaro A, Bruttomesso D, Filippi A, Scotton R, Magni L, Lanzola G, Di Palma F, Soru P, Toffanin C, De Nicolao G, Arnolds S, Benesch C, Heinemann L: Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management. Diabetes Care 2013;36: 3882-3887.
11. AP@home EU-FP7 Project. www.apathome.eu/ (accessed April 28, 2013).
12. Cobelli C, Renard E, Kovatchev B, Keith-Hynes P, Ben Brahim N, Place J, Del Favero S, Breton M, Farret A, Bruttomesso D, Dassau E, Zisser H, Doyle F III, Patek S, Avogaro A: Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes. Diabetes Care 2012;35:e65-e67.
13. Kovatchev B, Renard E, Cobelli C, Zisser H, Keith-Hynes P, Anderson S, Brown S, Chernavvsky D, Breton M, Farret A, Pelletier M, Place J, Bruttomesso D, Del Favero S, Visentin R, Filippi A, Scotton R, Avogaro A, Doyle F III: Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. Diabetes Care 2013;36:1851-1858.
14. Del Favero S, Bruttomesso D, Di Palma F, Lanzola G, Visentin R, Filippi A, Scotton R, Toffanin C, Messori M, Scarpellini S, Keith-Hynes P, Kovatchev BP, DeVries JH, Renard E, Magni L, Avogaro A, Cobelli C: First use of model predictive control in outpatient wearable artificial pancreas. Diabetes Care 2014;37:1212-1215.
15. Del Favero S, Place J, Kropff J, Messori M, Keith-Hynes P, Visentin R, Monaro M, Galasso S, Boscari F, Toffanin C, Di Palma F, Lanzola G, Scarpellini S, Farret A, Kovatchev B, Avogaro A, Magni L, Bruttomesso D, DeVries JH, Cobelli C, Renard E; AP@home Consortium: Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes. Diabetes Obes Metab 2015 Jan 20. 10.1111/dom.12440. [Epub ahead of print]
16. Facchinetti A, Del Favero S, Sparacino G, Castle JR, Ward WK, Cobelli C: Modeling the glucose sensor error. IEEE Trans Biomed Eng 2014;61:620-629.
17. Hovorka R, Nodale M Response to Mitre et al.: ''Analysis of continuous glucose monitoring data to assess outpatient closed-loop studies: considerations for different sensors.'' Diabetes Technol Ther 2014;16328-329.